Rheumatology Advance Access originally published online on July 9, 2009
Rheumatology 2009 48(9):1179; doi:10.1093/rheumatology/kep186
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Comment on: British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years): reply
1Department of Rheumatology, Nuffield Orthopaedic Centre, 2Biomedical Research Unit, Botnar Research Centre, University of Oxford, Oxford, 3Royal College of Nursing, London, 4National Rheumatoid Arthritis Society, Maidenhead, 5Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham and 6Rheumatology Department, Derbyshire Royal Infirmary, Derby, UK
Correspondence to: Raashid Luqmani, Department of Rheumatology, Nuffield Orthopaedic Centre, Windmill Road, Oxford, OX3 7LD, UK. E-mail: Raashid.luqmani@noc.nhs.uk
| The first 10% of the full text of this article appears below. |
SIR, We thank McLaren and colleagues [1] for raising a difficult issue, which we all wrestled with when developing the BSR/BHPR guidelines [2] and also with the recently published NICE RA Guidelines [3]. The issue over what constitutes optimal treatment is an ongoing area of concern for all. It has been